Bulletin from the Annual General Meeting in Hansa Biopharma AB (publ)
Lund, Sweden May 12, 2021 Hansa Biopharma AB (publ) has today on May 12, 2021 held its Annual General Meeting. In order to mitigate the spread of Covid-19, the Annual General Meeting was conducted by advance voting only, without physical presence of shareholders, proxies and third parties. The Annual General Meeting of Hansa Biopharma AB (publ) (the “Company”) passed the following resolutions. Resolution regarding the adoption of the income statement and the balance sheet as well as consolidated income statement and consolidated balance sheet, appropriation of result and discharge from